Results
|
36301.
|
|
|
36302.
|
|
|
36303.
|
|
|
36304.
|
|
|
36305.
|
|
|
36306.
|
Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. [electronic resource] by
- Thomas, Deborah A
- O'Brien, Susan
- Faderl, Stefan
- Garcia-Manero, Guillermo
- Ferrajoli, Alessandra
- Wierda, William
- Ravandi, Farhad
- Verstovsek, Srdan
- Jorgensen, Jeffrey L
- Bueso-Ramos, Carlos
- Andreeff, Michael
- Pierce, Sherry
- Garris, Rebecca
- Keating, Michael J
- Cortes, Jorge
- Kantarjian, Hagop M
Producer: 20100906
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
36307.
|
|
|
36308.
|
|
|
36309.
|
|
|
36310.
|
Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study. [electronic resource] by
- Pavlovsky, Santiago
- Corrado, Claudia
- Pavlovsky, Miguel A
- Prates, María V
- Zoppegno, Lucía
- Giunta, Mario
- Cerutti, Ider
- Palomino, Elsa
- Pagani, Fernando
- Lastiri, Francisco
- Bar, Daniel
- Bezares, Raimundo F
- Avila, Graciela
Producer: 20100820
In:
Clinical lymphoma, myeloma & leukemia vol. 10
Availability: No items available.
|
|
36311.
|
|
|
36312.
|
|
|
36313.
|
|
|
36314.
|
|
|
36315.
|
|
|
36316.
|
|
|
36317.
|
|
|
36318.
|
|
|
36319.
|
|
|
36320.
|
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. [electronic resource] by
- Serada, Satoshi
- Fujimoto, Minoru
- Terabe, Fumitaka
- Iijima, Hideki
- Shinzaki, Shinichiro
- Matsuzaki, Shinya
- Ohkawara, Tomoharu
- Nezu, Riichiro
- Nakajima, Sachiko
- Kobayashi, Taku
- Plevy, Scott Eric
- Takehara, Tetsuo
- Naka, Tetsuji
Producer: 20130404
In:
Inflammatory bowel diseases vol. 18
Availability: No items available.
|